ImmunityBio, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Results of Operations and Financial Condition

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Other Events

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Other Events

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Automatic Shelf Registration

Registration statement under Securities Act of 1933

06b

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

No description available

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

06b

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

No description available

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

No description available

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

No description available

Definitive Proxy Statement

No description available

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Simon Barry J.

Cohen Cheryl

Cambridge Equities, LP

Selecky Christobel

Cohen Cheryl

Cohen Cheryl

Selecky Christobel

Selecky Christobel

Selecky Christobel

Selecky Christobel

Simon Barry J.

MAXWELL LINDA

BLASZYK MICHAEL D

Cohen Cheryl

Wendel Bruce

Clark Wesley

Selecky Christobel

Simon Barry J.

Simon Barry J.

SOON-SHIONG PATRICK; CALIFORNIA CAPITAL EQUITY, LLC; Nant Capital, LLC; MP 13 Ventures, LLC; Cambridge Equities, LP

Annual Report Scanned (Paper)

Definitive information statement

Annual Report Scanned (Paper)

Correspondence with the SEC

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Definitive information statement

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Post-effective amendment filed solely to add exhibits

Post-effective amendment to an automatic shelf registration statement

Definitive information statement

Correspondence with the SEC

Letter from the SEC

Letter from the SEC